T2 heterogeneity: a novel marker of microstructural integrity associated with cognitive decline in people with mild cognitive impairment

BACKGROUND: Early Alzheimer’s disease (AD) diagnosis is vital for development of disease-modifying therapies. Prior to significant brain tissue atrophy, several microstructural changes take place as a result of Alzheimer’s pathology. These include deposition of amyloid, tau and iron, as well as alte...

Descripción completa

Detalles Bibliográficos
Autores principales: Wearn, Alfie R., Nurdal, Volkan, Saunders-Jennings, Esther, Knight, Michael J., Isotalus, Hanna K., Dillon, Serena, Tsivos, Demitra, Kauppinen, Risto A., Coulthard, Elizabeth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488446/
https://www.ncbi.nlm.nih.gov/pubmed/32912337
http://dx.doi.org/10.1186/s13195-020-00672-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488446/
https://www.ncbi.nlm.nih.gov/pubmed/32912337
http://dx.doi.org/10.1186/s13195-020-00672-9

Ejemplares similares